Cas:439290-35-4 Fmoc-Hyp-OBz manufacturer & supplier

Chemical Name:Fmoc-Hyp-OBz

CAS.NO:439290-35-4

Synonyms:2-Benzyl 1-(9H-fluoren-9-ylmethyl) (2S,4S)-4-hydroxy-1,2-pyrrolidinedicarboxylate;(2S,4S)-1-((9H-Fluoren-9-yl)methyl) 2-benzyl 4-hydroxypyrrolidine-1,2-dicarboxylate;1,2-Pyrrolidinedicarboxylic acid, 4-hydroxy-, 1-(9H-fluoren-9-ylmethyl) 2-(phenylmethyl) ester, (2S,4S)-;Fmoc-Hyp-obz;Fmoc-Hyp-Obzl

Molecular Formula:C₂₇H₂₅NO₅

Molecular Weight:443.491

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:621.0±55.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.642

PSA:76.07000

Exact Mass:443.173279

LogP:4.00

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Benzyl 1-(9H-fluoren-9-ylmethyl) (2S,4S)-4-hydroxy-1,2-pyrrolidinedicarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-Hyp-Obzl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fmoc-Hyp-obz Use and application,Fmoc-Hyp-Obzl technical grade,usp/ep/jp grade.

Related News: A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. Fmoc-Hyp-OBz manufacturer Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. Fmoc-Hyp-OBz supplier There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. Fmoc-Hyp-OBz vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. Fmoc-Hyp-OBz factory A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus.